- EFA response to EMA public consultation on Drug-Device Combination
- In June, the European Medicines Agency (EMA) launched a public consultation on the basis of a draft guideline discussing the ‘Quality requirements for drug-device combinations’. The draft guideline pr ...
- EFA at European Health Stakeholder Meeting in the European Parliament
- On September 12th, EFA participated in a panel-discussion in the European Parliament on “Brexit: the European Parliaments’ role in prioritising patients, public health and health security across Europ ...
- EFA response to HMA public consultation on allergen product development
- In April, the network of Heads of Medicines Agencies in the EU (HMA) launched a public consultation on common regulatory approaches for allergen products. The consultation puts several draft recommend ...
- WHO publishes 2019 report on the global tobacco epidemic
- The World Health Organisation (WHO) has published the 7th WHO Report on the Global Tobacco Epidemic. This year, the report focused on the progress that countries have made to help tobacco users quit. ...
- CONNECARE – personalized connected care for complex chronic patients
- Seven out of 10 hospital beds across Europe are occupied by people with chronic long-term conditions. The EU funded CONNECARE project aims at developing, deploying and evaluating a novel smart, adapti ...
- International awareness days – great opportunities for patient groups
- International awareness days are an opportunity to educate the general public on specific issues. Especially for patient organisations, it is a great possibility to mobilise political will and resourc ...
- CURE project shows good mid-term results
- Despite great advances in research, unfortunately, there is still no cure for asthma. The CURE project, funded by the EU, is looking at possible innovative solutions, such as bacteriophages, a type of ...
- Danish politicians tested for allergies
- In September, EFA member Asthma and Allergy Denmark has carried out a campaign specially focussed on the lack of specialists and asking for greater capacity in healthcare for the 1.5 million people wi ...
- Back to school – Being prepared with allergy
- EFA member Allergy UK has collected a variety of resources for students, parents and carers to empower parents and children feeling safe in school despite having allergies, available here. The Schools ...
- Food allergen regulation around the world
- EFA member Dutch Food Allergies Foundation, has shared an interactive chart providing interesting information on food allergen regulation around the world. The chart can be accessed here.
- COPD: Substances at work have same effect as smoking
- EFA member Long Fonds has published results of a research indicating that substances at work can cause COPD when being inhaled. The study carried out by Marike Boezen of UMC Groningen claims that “the ...
- Outdoor public places smoke-free in Sweden
- The Swedish government banned smoking in outdoor public places from July 1st. The following places should now be smoke-free: entrances to public buildings, places waiting for public transport, outdoor ...
- Survey on the use of lay language summaries in paediatric clinical trials
- The European Forum of Good Clinical Practices (EFGCP) in collaboration with the European Federation of Pharmaceutical Industries and Association (EFPIA) are working together to understand what is the ...
- Join us on the 2nd World Atopic Eczema Day on September 14th
- On September 14th, EFA, together with Global Skin, is marking World Atopic Eczema Day. With the day’s theme BENEATH THE SURFACE we raise awareness and understanding of this allergic skin disease. We i ...
- EFA at the Patient Access Partnership conference on the Future of Health
- On 11 and 12 July, EFA was proud to contribute to the high-level conference of Patient Access Partnership (PACT) on ‘The Future of Health: Advancing the UN 2030 Sustainable Development Agenda in Europ ...
- Save the Date: World Atopic Eczema Day 14th September
- On September 14th, EFA together with Global Skin we are marking the 2nd World Atopic Eczema Day with the theme BENEATH THE SURFACE to raise awareness and understanding of this allergic skin disease. A ...
- EFA response to EMA consultation on allergen product development in low-sized populations
- The European Medicines Agency (EMA) launched a public consultation on the basis of a concept paper for a ‘Guideline for allergen products development in moderate to low-sized study populations’. The ...
- EFA Response to EMA Public Consultation on Patient Registries
- The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries for regulatory purposes – methodological and op ...
- EFA response to WHO invitation for public comment: Global Action Plan for Healthy Lives and Well-being
- EFA provided input in the call for comments organised by the World Health Organisation (WHO), regarding strengthening collaboration among multilateral health organisations to accelerate country progre ...
- Medical Devices Regulation - Guidance on graphical symbols
- The Medical Devices Regulation (2017/745 EU) entered into force in 2017 with rules being applicable after a transitional period ending in spring 2020. The new regulation contains a series of important ...